Status:
COMPLETED
Comparison of Two Therapeutic Strategies of Dermoval in Treatment of Bullous Pemphigus
Lead Sponsor:
University Hospital, Rouen
Conditions:
Bullous Pemphigoid
Eligibility:
All Genders
18+ years
Brief Summary
to compare efficacity and tolerance of two stratégies of dermoval application in treatment of bullous pemphigus.
Eligibility Criteria
Inclusion
- age \> 18
- immunoflurescence, histological exam, predictive value according to bullous pemphigus diagnostic
- consentment patient
Exclusion
- age \< 18
- no consentment
- localized bullous pemphigus (\<400cm2)
- linear IgA pemphigus
- corticothérapy, immunotherapy
- pregnant woman pemphigus
Key Trial Info
Start Date :
August 1 2001
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2008
Estimated Enrollment :
330 Patients enrolled
Trial Details
Trial ID
NCT00213421
Start Date
August 1 2001
End Date
November 1 2008
Last Update
June 18 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UH-rouen
Rouen, Seine maritime, France, 76000